zhenhua chemical(SH:603067)2023-04-24 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥849,988,097.42, representing a year-on-year increase of 7.56%[5] - The net profit attributable to shareholders for the same period was ¥101,952,932.44, with a growth of 2.40% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥105,384,424.90, reflecting a 4.60% increase year-on-year[5] - Total operating revenue for Q1 2023 was ¥849,988,097.42, an increase of 7.5% compared to ¥790,212,377.27 in Q1 2022[19] - Net profit for Q1 2023 was ¥99,404,376.82, slightly down from ¥99,696,464.50 in Q1 2022, representing a decrease of 0.3%[20] - Earnings per share for Q1 2023 remained stable at ¥0.20, consistent with Q1 2022[21] - The net profit for Q1 2023 was CNY 49,168,262.46, up 7.2% from CNY 45,535,566.29 in Q1 2022[30] Cash Flow and Liquidity - The net cash flow from operating activities decreased significantly by 62.83%, amounting to ¥39,514,062.12[5] - Cash inflow from operating activities in Q1 2023 was CNY 474,820,064.91, a decrease of 28.7% compared to CNY 665,044,192.64 in Q1 2022[24] - Net cash flow from operating activities in Q1 2023 was CNY 39,514,062.12, down 62.9% from CNY 106,318,988.57 in Q1 2022[24] - Cash and cash equivalents decreased by 46.77% due to reduced cash flow from operating activities[9] - Cash and cash equivalents at the end of Q1 2023 were CNY 131,926,723.07, slightly down from CNY 133,436,983.90 at the end of Q1 2022[25] - The cash and cash equivalents at the end of Q1 2023 were CNY 28,273,577.38, down from CNY 84,621,091.19 at the end of Q1 2022[33] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,051,461,372.44, an increase of 1.76% from the end of the previous year[6] - The company's total liabilities as of March 31, 2023, were ¥1,390,883,150.33, a decrease from ¥1,424,979,052.98 at the end of 2022[18] - The total assets as of March 31, 2023, were ¥4,051,461,372.44, up from ¥3,981,262,232.97 at the end of 2022[18] - The total liabilities decreased to CNY 1,200,788,011.49 in Q1 2023 from CNY 1,224,384,454.81 in Q4 2022, a reduction of approximately 2.0%[28] - Current liabilities as of March 31, 2023, were CNY 820,534,281.54, a decrease from CNY 849,082,401.94 as of December 31, 2022[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 29,394[10] - The top shareholder held 37.16% of the shares, while the second-largest shareholder held 3.59%[11] Research and Development - Research and development expenses for Q1 2023 were ¥21,619,303.74, down from ¥27,318,027.86 in Q1 2022, indicating a reduction of 20.9%[19] - Research and development expenses for Q1 2023 were CNY 13,899,689.05, slightly down from CNY 14,072,711.31 in Q1 2022[30] Operational Changes - The company reported a 92.71% decrease in asset disposal income, indicating a decline in asset sales[9] - The company's long-term equity investments decreased from RMB 3,222,940.52 to RMB 2,993,729.24, a decline of about 7.10%[16] - The company reported a significant increase in accounts payable, rising to RMB 230,126,255.89 from RMB 180,317,965.20, an increase of approximately 27.63%[16] - The company has not disclosed any new product developments or market expansion strategies in the current report[14] - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[34]